Clinical trial Recruiting at 1 site Interventional Ages 24 Weeks to 32 Weeks

Using a blood warmer to prevent hypothermia in preterm infants during blood transfusions

Official title: Evaluation of a Blood Warming Device for Packed Red Blood Cell Transfusions to Decrease Hypothermia in Very Preterm Infants

Run by University of South Carolina · NCT05170633 · Data updated 2026-11-12

This study is testing if using a blood warmer during blood transfusions can help very preterm infants stay warm and avoid hypothermia.

More Preterm Birth trials

Quick facts

Study typeInterventional
Ages24 Weeks to 32 Weeks
SexAll
Enrollment140 (estimated)
SponsorUniversity of South Carolina
Academic / other
Locations1 site (Columbia, South Carolina)
StatusRecruiting
StartedJanuary 1, 2022
Main results expectedJanuary 1, 2026
Study endsJanuary 1, 2026
Registry record updatedDecember 11, 2024
Trial IDNCT05170633 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are infants born at less than 32 weeks gestational age who are admitted to the neonatal intensive care unit and require a PRBC transfusion within their first month of life.

Probably not a fit

Patients with neurological anatomical abnormalities or major brain hemorrhage (Grade III or IV) may not benefit from this study due to their compromised thermal control.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial aims to improve the care of very preterm infants by using a Ranger blood warmer during packed red blood cell (PRBC) transfusions to prevent hypothermia. The study will involve 140 infants born at less than 32 weeks gestational age who are admitted to the neonatal intensive care unit and require a PRBC transfusion within their first month of life. Researchers will compare the body temperatures of infants receiving warmed blood to those receiving standard transfusions to assess the effectiveness of this intervention in reducing hypothermia. The trial is based on previous findings that highlight the risk of hypothermia during blood transfusions in this vulnerable population.

Why it matters

Potential benefit: If successful, this approach could significantly reduce the incidence of hypothermia in very preterm infants during blood transfusions, potentially improving their overall health outcomes.

How similar studies have gone: While there has been limited research specifically on warming PRBC transfusions in preterm infants, the approach of preventing hypothermia in neonatal care has shown promise in other contexts.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Any infant born at PRISMA Health Richland hospital
* less than 32 weeks gestational age by obstetrical dating as indicated in the electronic medical chart
* admitted to the neonatal intensive care unit receiving one PRBC transfusion within the first month of life.

Exclusion Criteria:

* Infants having neurological anatomical abnormalities or major brain hemorrhage (Grade III or IV), because neurological damage can interfere with thermal control.

Where it's running

  • Kayla Everhart
    Columbia, South Carolina, United States
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.